Intra-Cellular Therapies Inc (NASDAQ:ITCI)

Delayed Data
As of 3:59pm ET
 +0.48 / +0.89%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 12 analysts offering 12-month price forecasts for Intra-Cellular Therapies Inc have a median target of 77.50, with a high estimate of 100.00 and a low estimate of 59.00. The median estimate represents a +42.86% increase from the last price of 54.25.

Analyst Recommendations

The current consensus among 13 polled investment analysts is to Buy stock in Intra-Cellular Therapies Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -35.62%
Growthannually 15.94%


Growthquarterly 5.30%
Growthannually 79.85%
Key to the earnings and sales forecast charts.